In human breast cancer cells, delphinidin (Figure 5B) treatment inhibited cell proliferation by blocking the Akt signaling pathway and inducing apoptosis by increasing Bcl-2 expression along with increasing Bax expression in a dose-dependent manner [75]. The gene discussed is BCL2; the disease is breast carcinoma.